Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ramosetron vs Ondansetron for PONV Prevention in Total Knee Arthroplasty
NCT02830906Phase 3Completed
- Sponsor
- Thammasat University
- Start
- Apr 2014
- Primary completion
- Feb 2015
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of ramosetron in postoperative nausea and vomiting (PONV), sponsored by Thammasat University. Started Apr 2014; status: completed.
02
Drugs
ramosetron
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on NCT02830906.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02830906.